Category Archives: Vioxx

Featured Stories

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Do Vitamin Drinks Pose Health Risks?Do Vitamin Drinks Pose Health Risks?

Do Vitamin Drinks Pose Health Risks?

Scientists are concerned vitamin drinks are contributing to levels of vitamins and other nutrients that are not only unnecessary, but potentially harmful.

Read More

New York Property Owners Challenge Binghamton Fracking Ban

According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

3 people, injured on Wednesday at 1:20 p.m. when a LIRR train hit a livery cab on the tracks west of Wyandanch station. The train engineer, who suffered a shoulder injury.

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

E-cigarettes Could Increase Risk of Lung Infections

E-cigarettes Could Increase Risk of Lung Infections

New research suggests the liquid used in electronic cigarettes could increase the risk of viral lung infections, regardless of whether it contains nicotine.

Read More

Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings

Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

Vioxx Off-Label Marketing To Cost Merck $321 Million

Vioxx off-label marketing activities are going to cost Merck & Co. a whopping $321 million in criminal fines. The U.S. Food & Drug Administration (FDA) approved Vioxx (rofecoxib), a painkiller, for three indications in May 1999. Merck has pleaded guilty … Continue reading

Posted in Pharmaceuticals, Vioxx, Vioxx | Tagged |

Merck Agrees to Pay $950 Million to Settle Vioxx Marketing Charges

Merck has agreed to pay $950 million to settle Vioxx marketing charges. Pleading guilty to illegally advertising now-banned painkiller Vioxx (rofecoxib), Merck Sharp & Dohme will be paying millions in fines and penalties to the United States government as well … Continue reading

Posted in Pharmaceuticals, Vioxx |

Supreme Court Gives Go Ahead to Vioxx Investor Lawsuit

Yesterday, the U.S. Supreme Court gave the go-ahead for a securities fraud lawsuit against pharmaceutical giant, Merck & Co Inc., over its disclosures to investors about < "">Vioxx, said Reuters. Vioxx, was approved for use in 1999, quickly becoming a … Continue reading

Posted in Class Action Lawsuits, Health Concerns, Pharmaceuticals, Vioxx, Vioxx |

Merck Loses Australian Vioxx Lawsuit

We just wrote that Merck & Co. made a final $4.1 billion payment to its < "">Vioxx settlement fund. According to a recent Associated Press (AP) report, final payouts to former Vioxx users or their survivors should be made by … Continue reading

Posted in Class Action Lawsuits, Vioxx |

Vioxx Shareholder Lawsuit Before US Supreme Court

Readers of this blog are, by now, aware of the many issues surrounding Merck’s blockbuster nonsteroidal, anti-inflammatory medication < "">Vioxx (rofecoxib) and negative cardiac events. The cardiac problems associated with Vioxx, and its subsequent withdrawal from the market, spawned scores … Continue reading

Posted in Pharmaceuticals, Vioxx, Vioxx |

Researcher Faked Data for 21 Studies Involving Vioxx, Celebrex and Other Drugs

Medical journals have been asked to retract 21 studies that touted the benefits of < "">Vioxx, < "">Celebrex and other drugs. According to The Wall Street Journal, Baystate Medical Center, Springfield, Mass. is asking the journals to make the retractions … Continue reading

Posted in Class Action Lawsuits, Pharmaceuticals, Vioxx, Vioxx |

Vioxx Grand Jury Probe Latest Headache for Merck

Just as < "">Vioxx maker Merck gets closer to settling thousands of lawsuits against the defective pain reliever, reports have surfaced that a grand jury is investigating the company over the way it marketed Vioxx. According to the Wall Street … Continue reading

Posted in Class Action Lawsuits, Legal News, Pharmaceuticals, Vioxx, Vioxx |

Florida Vioxx Plaintiffs Look to Expand Settlement

< "">Vioxx plaintiffs in Florida are petitioning a federal court to expand Merck’s proposed $4.85 billion settlement to include those who did not file suit against the company by Nov. 9, 2007.  But many lawyers involved in the Vioxx settlement … Continue reading

Posted in Class Action Lawsuits, Legal News, Pharmaceuticals, Vioxx, Vioxx |

Vioxx Victims to Share $4.85 Billion under Settlement Agreement with Merck

Vioxx maker Merck will spend $4.85 billion to settle a significant number of lawsuits filed against it for injuries caused by the painkiller. Under the agreement, which was announced late yesterday, Merck will set up two separate settlement funds to … Continue reading

Posted in Class Action Lawsuits, Legal News, Pharmaceuticals, Product Recalls, Recalled Drugs, Vioxx, Vioxx |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.